Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
72
Views
3
CrossRef citations to date
0
Altmetric
Review

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis

Jennifer Reardon1 Weill Cornell MS Center at Nyack Hospital, Nyack Hospital, Nyack, NY, USA
&
Jai S Perumal1 Weill Cornell MS Center at Nyack Hospital, Nyack Hospital, Nyack, NY, USA;2 Department of Neurology, Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
Pages 1187-1193 | Published online: 09 Oct 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Y. Zhang, W. Jin & X. Cai. (2017) Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver transplant recipients: a systematic review and meta-analysis. Annals of Medicine 49:5, pages 365-376.
Read now

Articles from other publishers (2)

Bonaventura Casanova, Carlos Quintanilla-Bordás & Francisco Gascón. (2022) Escalation vs. Early Intense Therapy in Multiple Sclerosis. Journal of Personalized Medicine 12:1, pages 119.
Crossref
Diana L Vargas & William R Tyor. (2023) Update on Disease-Modifying Therapies for Multiple Sclerosis. Journal of Investigative Medicine 65:5, pages 883-891.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.